Patch Testing Outcomes in Pediatric Allergic Contact Dermatitis

In a presentation by Shana George, a rising medical student, the focus is on allergic contact dermatitis (ACD) in pediatric patients and the outcomes of patch testing. ACD affects 16.5% of children globally and is often found alongside atopic dermatitis (AD), complicating diagnosis due to similar clinical presentations. Misdiagnosis can lead to poorly controlled dermatitis and diminished quality of life. The study conducted at Massachusetts General Hospital aimed to analyze the effectiveness of patch testing in children, given the lack of existing literature on this aspect. The retrospective study included children who underwent patch testing between 2017 and 2022, with 51 patients providing follow-up data. Findings revealed that 27% of children achieved complete resolution, 55% had partial resolution, while 17% showed no improvement, highlighting that a significant 82% experienced at least some degree of improvement through allergen avoidance. Common allergens identified included fragrances, metals, and preservatives. The study suggests that successful management of ACD can significantly enhance the clinical outcomes for children, particularly in the context of co-existing AD. Recommendations for future research include larger studies and investigations into adherence to allergen avoidance and comparative outcomes between patients with and without AD. Overall, patch testing appears vital in managing ACD in children to improve their quality of life.